Clinical Trial Update: Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating maintenance antiretroviral therapy with DOR/3TC versus DTG/3TC in people living with HIV-1 infection; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DOR/3TC (doravirine + lamivudine)
• DTG/3TC (dolutegravir/lamivudine)

Snippet

Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | Conditions: HIV-1-infection | Phase 2 | Status: RECRUITING